Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 9, 2002, Pages 817-824

  Möller, Björn ^a   Lindblom, Bo ^a   Olovsson, Matts ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Endometrium; VEGF receptors; VEGF B; VEGF C

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; FEMALE; FEMALE FERTILITY; FEMALE STERILIZATION; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS BLEEDING;

ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MENSTRUAL CYCLE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, GROWTH FACTOR; RECEPTORS, MITOGEN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 0036715405     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.810903.x     Document Type: Article

References (37)

1. Signaling pathways induced by vascular endothelial growth factor
2. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR
3. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
4. Vascular endothelial growth factor: Molecular and biological aspects
5. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor s-flt in cycling human endometrium
6. VEGF, its receptors and the Tie receptors in recurrent miscarriage
7. Localized expression of the angiogenic growth factors vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF-2), epidermal growth factor (EGF), and their receptors in normal human endometrium during the menstrual cycle
8. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
9. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia
10. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
11. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells
12. Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors
13. Current biology of VEGF-B and VEGF-C
14. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells
15. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
16. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
17. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors
18. Avian VEGF-C: Cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors
19. Dating the endometrial biopsy
20. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
21. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
22. Expression of vascular endothelial growth factor receptors in the human endometrium: Modulation during the menstrual cycle
23. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform
24. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
25. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues
26. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells
27. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
28. Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitro
29. Genomic organization of human and mouse genes for vascular endothelial growth factor C
30. NF-kappa B: A pleiotropic mediator of inducible and tissue-specific gene control
31. NF-kappa B: Ten years after
32. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
33. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: Potential relevance to menstruation
34. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells
35. Ovarian steroids regulate the expression of basic fibroblast growth factor and its mRNA in fibroblasts derived from uterine endometrium
36. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
37. Vascular endothelial growth factor C induces angiogenesis in vivo